martes, 6 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· July 16, 2026

FreightWaves Announces 2026 AI Excellence in Supply Chain Awards Winners

View original at finance.yahoo.com
FreightWaves Announces 2026 AI Excellence in Supply Chain Awards Winners CHICAGO — FreightWaves unveiled the winners of its 2026 AI Excellence in Supply Chain Awards during a ceremony at the Old Post Office in Chicago as part of the FreightWaves Supply Chain AI Symposium on July 15, 2026…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • A global medical device manufacturer using Arkestro compressed logistics RFQ timelines from four months to six weeks, saving $2.4 million.

    60% confidence

  • ROI modeling across CloneOps.ai's agent portfolio shows the potential to eliminate more than 133 human hours per 1,000 calls, with representative workflows delivering up to 550% ROI compared with U.S.-based labor.

    60% confidence

  • Arkestro customers report an average 18.8% savings on spend and sourcing cycles accelerated by up to 60%.

    60% confidence

  • An LNG operator using Arkestro cut high-value sourcing cycles from days to minutes while achieving 29% savings.

    60% confidence

  • FreightWaves received a record 60 nominations for the 2026 AI Excellence in Supply Chain Awards, more than double last year's total.

    60% confidence

  • A manufacturer using Arkestro's platform identified more than $55 million in savings with a two-month ROI across 40 plants and more than 400 suppliers.

    60% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
FreightWaves Announces 2026 AI Excellence in Supply Chain Awards Winners — Source | Via News | es.VIA.NEWS